Editorials

Preventing malaria in UK travellers

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7461.305 (Published 05 August 2004) Cite this as: BMJ 2004;329:305
  1. Jane N Zuckerman (j.zuckerman@rfc.ucl.ac.uk), director
  1. WHO Collaborating Centre in Travel Medicine, Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, London NW3 2PF

    Guidelines stress the need for compliance with prophylaxis and standby medication

    The advisory committee on malaria prevention for UK travellers has updated the guidance for healthcare professionals who advise travellers.1 Noteworthy changes have been made in the advice from the guidelines produced previously. The new guidance places greater emphasis on the use of certain malaria chemoprophylaxis and has important changes regarding emergency standby medication.

    Worldwide, over 40% of the population lives in malarious areas with an estimated 300-500 million cases of malaria occurring each year resulting in up to two million deaths.2 Importantly malaria is one of the most common causes of serious illness in the returning traveller. At least 2000 cases (10 000 in Europe3) are imported into the United Kingdom each year, and nine of these on average result in death. The proportion of cases due to Plasmodium falciparum has continued to rise, accounting for more than half of the cases.1 4

    Low price travel has led to increasing numbers of travellers visiting areas where malaria is endemic. Few of these travellers seek travel health advice before departure; the results of a study …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe